Johan Harmenberg

Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study

Sten Nilsson, Lars Franzén, Christopher Parker et al. · The Lancet Oncology · 2007 · 491 citations

Bone-targeted Radium-223, Urology, Genitourinary Cancer +6

Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma

Paul G. Richardson, Albert Oriol, Alessandra Larocca et al. · Journal of Clinical Oncology · 2020 · 146 citations · Full text

The mechanism of action of the anti-herpes virus compound 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline

Johan Harmenberg, Annelie Åkesson-Johansson, Astrid Gräslund et al. · Antiviral Research · 1991 · 94 citations

Medicinal Chemistry, Anti-herpes Virus Compound, Molecular Virology +6

Antiherpesvirus activity and mechanism of action of indolo-(2,3-b)quinoxaline and analogs

Johan Harmenberg, Britta Wahrén, J. BERGMAN et al. · Antimicrobial Agents and Chemotherapy · 1988 · 92 citations

Molecular Virology, Synthetic Virology, Cellular Toxicity +11

Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1–2 study

Paul G. Richardson, Sara Bringhen, Peter M. Voorhees et al. · The Lancet Haematology · 2020 · 86 citations

Hematological Malignancy, Medicine, Immunology +6